BRENT KLEIER: Open Payments
NPI 1689342974 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 40 payments from 8 companies in 2025. Trend: 2023 $354 · 2024 $1,102 · 2025 $678
Food & beverage: $601Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $178 |
| Ardelyx, Inc. | 11 | $151 |
| Janssen Biotech, Inc. | 4 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 7 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Organon LLC | 1 | $20 |
Products named: IBSRELA, TREMFYA, RINVOQ, ENTYVIO, CREON, VOQUEZNA, LINZESS, DUPIXENT.
Industry payments across KY — which companies pay providers there.
